**"BioNexus Gene Lab's 11.04% Revenue Surge: Harnessing Market Demand and Innovation for Competitive Edge

Financial Performance

BioNexus Gene Lab (BGLC) achieved an operating revenue of RMB252.3855 million in 2024, up 11.04% from RMB227.3067 million in 2023. This growth indicates a strong market performance, possibly due to the launch of new products and increased market demand.

Key Financial Data

1. BGLC's operating revenue increased from RMB227.3067 million to RMB252.3855 million, an increase of RMB25.0788 million, or 11.04%.

2. The growth may be attributed to the launch of new products, adjustments in sales strategies, expansion of the customer base, and improvement in the industry environment.

3. The overall operating revenue in the industry shows a growth trend, especially in the field of genetic testing and personalized medicine, and BGLC's performance is particularly outstanding.

Peer Comparison

1. Industry-wide analysis: The overall operating revenue of the biotechnology industry is affected by market demand and innovative products, with a general increase in 2024, especially in the field of genetic testing.

2. Peer evaluation analysis: BGLC's 11.04% operating revenue growth rate is outstanding among industry companies, with other companies' growth generally ranging from 5% to 10%, demonstrating BGLC's market competitiveness.

Summary

BGLC's operating revenue growth in 2024 is significant, mainly due to the rise in market demand and effective sales strategy adjustments. Despite the challenges faced by the industry as a whole, BGLC has achieved competitiveness through the launch of new products and market expansion.

Opportunities

1. Continue to launch new products to meet market demand, especially in the fields of genetic testing and personalized medicine.

2. Expand market coverage and sales channels to attract more customers.

3. Strengthen digital marketing and supply chain optimization to enhance marketing efficiency and customer satisfaction.

Risks

1. High turnover rates in the industry may lead to a shortage of human resources, affecting the company's operations.

2. Uncertainty in overall market demand may affect future revenue growth.

3. Competitors' performance and innovation capabilities may pose a threat to BGLC's market share.